Yan Luo, Bertarelli Daniela C G, Hayallah Alaa M, Meyer Heiko, Klotz Karl-Norbert, Müller Christa E
Pharmaceutical Institute, Pharmaceutical Chemistry Poppelsdorf, University of Bonn, Kreuzbergweg 26, D-53115 Bonn, Germany.
J Med Chem. 2006 Jul 13;49(14):4384-91. doi: 10.1021/jm060277v.
1-Propyl- and 1,3-dimethyl-8-p-sulfophenylxanthine (PSB-1115 and SPT) were used as starting compounds for the development of adenosine A(2B) receptor antagonists with a sulfonamide structure. Since standard reactions for sulfonamide formation failed or resulted in very low yields, we developed a new method for the preparation of sulfonamides. p-Nitrophenoxide was used as a suitable leaving group with well balanced stability-reactivity properties. A large variety of amines, including aniline, benzylamine, phenethylamine, propylamine, butylamine, 2-hydroxyethylamine, aminoacetic acid, and N-benzylpiperazine reacted with p-nitrophenoxysulfonylphenylxanthine derivatives yielding the desired sulfonamides in satisfying to very good yields. The obtained sulfonamides were much more potent at A(2B) receptors than the parent sulfonates. The most active compound of the present series was 8-[4-(4-benzylpiperazide-1-sulfonyl)phenyl]-1-propylxanthine (11, PSB-601) exhibiting a K(i) value of 3.6 nM for the human A(2B) receptor combined with high selectivity versus the other human adenosine receptor subtypes (575-fold versus A(1), 134-fold versus A(2A), and >278-fold versus A(3)).
1-丙基-和1,3-二甲基-8-对磺基苯基黄嘌呤(PSB-1115和SPT)被用作开发具有磺酰胺结构的腺苷A(2B)受体拮抗剂的起始化合物。由于磺酰胺形成的标准反应失败或产率极低,我们开发了一种制备磺酰胺的新方法。对硝基苯氧基用作具有良好稳定性-反应活性平衡性质的合适离去基团。包括苯胺、苄胺、苯乙胺、丙胺、丁胺、2-羟乙胺、氨基乙酸和N-苄基哌嗪在内的多种胺与对硝基苯氧基磺酰基苯基黄嘌呤衍生物反应,以令人满意到非常好的产率得到所需的磺酰胺。所得到的磺酰胺在A(2B)受体上的活性比母体磺酸盐高得多。本系列中最具活性的化合物是8-[4-(4-苄基哌嗪-1-磺酰基)phenyl]-1-丙基黄嘌呤(11,PSB-601),对人A(2B)受体的K(i)值为3.6 nM,对其他人类腺苷受体亚型具有高选择性(对A(1)为575倍,对A(2A)为134倍,对A(3)大于278倍)。